|
|
|
|
||
Dr Adler: next direction for CK is Parkinson's diseasehttp://stn.nsc.gov.tw/view_detail.asp?doc_uid=0981210044&kind_no=A07 ** translated from Chinese ** NSC International Cooperation Sci-Tech Newsbrief (Taiwan) Taiwan-US biomedical engineering Forum calls for interdisciplinary exchange Author: San Francisco Science and Technology Group Source: World Journal - California (Chinese newspaper), 1st Nov 2009 Published Date: 14 Dec 2009 The rapid development of modern engineering technology for the medical breakthrough. With minimally invasive surgery represents a new generation of medical technology has entered a practical stage, for the treatment of cancer and neurological diseases, provide new avenues. From the Bay Area, held various scientific and technological societies Taiwan and the United States in 2009 the second session of the Biomedical Engineering Forum, October 31, held in Santa Clara, with the theme "Biomedical engineering needs and solutions." A number of medical experts was invited to direct dialogue with the engineers to make the medical needs of engineers have a better understanding and thus make a living to provide more opportunities for innovation in medical engineering. ..... Stanford University School of Medicine professor of neurosurgery Dr. John Adler introduced the latest achievements in minimally invasive surgery. He said that minimally invasive surgery represented by Cyberknife has been used to treat lung cancer, prostate cancer and brain tumors. The next step is to treat neurological disorders such as Parkinson's disease. He pointed out that the world has successfully performed 80,000 cases of minimally invasive surgery, of which 5,000 cases completed at the Stanford School of Medicine. |
return to message board, top of board |